Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)
NCT ID: NCT01607632
Last Updated: 2012-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2010-01-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Loving-Kindness Meditation for PTSD
NCT01962714
Compassion Meditation for PTSD
NCT02372396
Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study
NCT00880152
Mindfulness and Present Centered Therapies for PTSD: Efficacy and Mechanisms
NCT01347749
A Multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTSD
NCT01532999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
loving-kindness meditation
loving-kindness meditation
A 12-week duration, 90 minute per session loving-kindness meditation course
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
loving-kindness meditation
A 12-week duration, 90 minute per session loving-kindness meditation course
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* borderline personality disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seattle Institute for Biomedical and Clinical Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Kearney
Staff Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Kearney, MD
Role: PRINCIPAL_INVESTIGATOR
VA Puget Sound
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Puget Sound
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00173
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.